1-3 of 3
Robert Oostendorp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Stefan Habringer, MD, Peter Herhaus, Margret Schottelius, PhD, Constantin Lapa, MD, Rouzanna Istvanffy, PhD, Katharina Götze, Katja Steiger, DVM, Binje Vick, PhD, Christian Peschel, MD, Robert Oostendorp, PhD, Irmela Jeremias, MD, Hans-Jürgen Wester, PhD, Goetz Ulrich Grigoleit, MD, Ulrich Keller, MD
Journal: Blood
Blood (2016) 128 (22): 4055.
https://doi.org/10.1182/blood.V128.22.4055.4055
Published: 2016
Journal Articles

Tyrosine Kinase Inhibition by SU5614 Fails To Eradicate Leukemic Stem Cells in FLT3-ITD+ Acute Myeloid Leukemia: Role of the Microenvironment.

Katharina S. Götze, MD, Sally Rushton, PhD, Stefanie Marz, Sabine Kayser, PhD, Konstanze Dohner, MD, Christian Peschel, MD, Robert Oostendorp, PhD
Journal: Blood
Blood (2007) 110 (11): 3382.
https://doi.org/10.1182/blood.V110.11.3382.3382
Published: 2007
Journal Articles

Evidence that ceramide mediates the ability of tumor necrosis factor to modulate primitive human hematopoietic cell fates

Veronique Maguer-Satta, Robert Oostendorp, Dianne Reid, Connie J. Eaves
Journal: Blood
Blood (2000) 96 (13): 4118–4123.
https://doi.org/10.1182/blood.V96.13.4118
Published: 2000